Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications

Joel Faintuch is a gastrointestinal surgeon, and former International Guest Fellow of the American College of Surgeons. He is Honorary Fellow of three Surgical Societies, and has served as Visiting Professor at the University of Maastricht. He was the pioneer of Parenteral and Enteral Nutrition in Brazil and South America, and a founding member of three medical societies. In the last years, his focus has been in the Intestinal Microbiome. Joel Faintuch is the author of over 250 articles in peer-reviewed journals, along with 10 books, three theses, and over 200 chapters in books, and other publications. Salomao Faintuch is the Clinical Director of Vascular and Interventional Radiology at Beth Israel Deaconess Medical Center and Harvard Medical School. He has authored more than 50 articles in peer-reviewed journals, along with 5 Society Guidelines and Standards of Practice and 3 textbooks. He is a Radiological Society of North America Research Scholar, serves in eight national society committees, and is member of the Editorial Board of three international journals.

• Block I Tools, Toolstations and Models1. Germ-Free Animals as a Tool to Study Indigenous Microbiota2. Germ-Free Mouse Technology in Cardiovascular Research3. The Gut Microbiome Beyond the BacteriomedThe Neglected Role of Virome and Mycobiome in Health and Disease4. Techniques for Phenotyping the Gut Microbiota Metabolome5. Metabolomics Tools and Information Retrieval in Microbiome Hacking6. Laboratory Simulators of the Colon Microbiome7. Potential of Metabolomics to Breath TestsBlock II Background Information8. Metabolome and Microbiome From Infancy to Elderly9. The Oral Microbiome10. The Gastric Microbiome in Benign and Malignant Diseases11. The Human Vaginal Microbiome12. Bioactive Molecules of the Human Microbiome: Skin, Respiratory Tract, Intestine13. Role of the Microbiome in Intestinal Barrier Function and Immune Defense14. The Cross Talk Between Bile Acids and Intestinal Microbiota: Focus on Metabolic Diseases and Bariatric SurgeryBlock III Established and Experimental Interventions15. Use of Probiotics in Inflammatory Bowel Disease16. Current Status of Fecal Microbiota Transplantation17. Effects of Probiotics on Improvement of Metabolic Factors in Pregnant Women: A Metaanalysis of Randomized Placebo-Controlled Trials18. Current Options for Fecal Transplantation in Clostridium difficile Infection19. Targeted Delivery of Bacteriophages to the Gastrointestinal Tract and Their Controlled Release: Unleashing the Therapeutic Potential of Phage Therapy20. The Unknown Effect of AntibioticInduced Dysbiosis on the Gut Microbiota21. The Myth and Therapeutic Potentials of PostbioticsBlock IV Diagnostic and Therapeutical Applications22. The Microbiome and Metabolome in Metabolic Syndrome23. The Gut Microbiota as a Therapeutic Approach for Obesity24. The Gut Microbiome After Bariatric Surgery25. Gut Dysbiosis in Arterial Hypertension: A Candidate Therapeutic Target for Blood Pressure Management26. The Emerging Role of MicrobiomeeGuteBrain Axis in Functional Gastrointestinal Disorders27. The Microbiome and Metabolome in Nonalcoholic Fatty Liver Disease28. The Microbiome and Metabolome in Alcoholic Liver Disease29. The Microbiome, Metabolome, and Proteome in Preterm Neonatal Sepsis30. Gut Microbiome in the Elderly Hospitalized Patient: A Marker of Disease and Prognosis?31. The Lung Microbiome, Metabolome, and Breath Volatolome in the Diagnosis of Pulmonary Disease